ReviewFrontiers in oncology2026

The diagnostic value of mpMRI and PSMA-targeted PET/CT in radiorecurrent prostate cancer: a narrative review.

Umberto Merani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.